Literature DB >> 3142068

The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis.

R J Winchester1, P K Gregersen.   

Abstract

This is an interpretive review of recent immunologic and molecular biologic data concerning the molecular basis of susceptibility to rheumatoid arthritis. The central point of view was taken that the major histocompatibility complex (MHC) class II molecules encoding disease susceptibility function in an immune recognition event involving an antigen "X" that currently eludes characterization. The problem of understanding the meaning of the association of susceptibility with diverse MHC alleles such as DR4 (Dw4 and Dw14), DR1, and DRw10 is approached by detailed biochemical analysis that led to the identification of common stretches of amino acid sequence, presumably encoding conformationally equivalent structures. Non-classic MHC polymorphisms related to disease susceptibility but not associated with particular alleles such as identified by Ab 109d6 proved especially valuable in suggesting new directions for attempting to understand the significance of these associations. Consideration is given to the possibility that a family of either slightly different or identical conformations encoded in either cis or trans cumulatively confer the liability to develop rheumatoid arthritis, and implying a highly non-classic mode of inheritance. The available data do not permit a distinction between the possibilities that an antigen "X" was being presented to T cells or whether the distinctive conformations of the MHC class II molecule serve the same role as antigen "X" but are directly recognized by T cells. However, with additional data, some limited insight should be able to be inferred about the nature of an antigen "X" that specifically binds to the MHC conformation with a complementary interaction. It seems reasonable to consider the pathogenesis of rheumatoid arthritis as a typical immune response resulting from a simple immune recognition event of a single antigenic molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142068     DOI: 10.1007/bf01857219

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  53 in total

Review 1.  Multiple HLA associations and disease susceptibility.

Authors:  J A Sachs; J R Kirwan
Journal:  Dis Markers       Date:  1986-06       Impact factor: 3.434

2.  Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain.

Authors:  A Schamboeck; A J Korman; A Kamb; J L Strominger
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

3.  Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO.

Authors:  S Shaw; P Kavathas; M S Pollack; D Charmot; C Mawas
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

4.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.

Authors:  B Schiff; Y Mizrachi; S Orgad; M Yaron; E Gazit
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

5.  HLA-DR antigens and disease patterns of rheumatoid arthritis.

Authors:  O Scherak; J S Smolen; W R Mayr
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

6.  A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing.

Authors:  D W Andrews; M R Bono; J L Strominger
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

7.  Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.

Authors:  R W Karr; G E Rodey; T Lee; B D Schwartz
Journal:  Arthritis Rheum       Date:  1980-11

8.  Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  A Gibofsky; R Winchester; J Hansen; M Patarroyo; B Dupont; S Paget; R Lahita; J Halper; M Fotino; E Yunis; H G Kunkel
Journal:  Arthritis Rheum       Date:  1978-06

9.  Immunologically relevant peptide antigen exists on the presenting cell in a manner accessible to macromolecules in solution.

Authors:  K B Cease; G Buckenmeyer; I Berkower; J York-Jolley; J A Berzofsky
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Antigen presentation by murine and human cells to a murine T-cell hybridoma: demonstration of a restriction element associated with a major histocompatibility complex class II determinant(s) shared by both species.

Authors:  S J Waters; R J Winchester; F Nagase; G J Thorbecke; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 12.779

View more
  13 in total

1.  Dual antigenic recognition by cloned human gamma delta T cells.

Authors:  J Holoshitz; L M Vila; B J Keroack; D R McKinley; N K Bayne
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 2.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

Review 3.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s.

Authors:  E D Harris
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

Review 5.  The B cell system in the rheumatoid inflammation. New insights into the pathogenesis of rheumatoid arthritis using synovial B cell hybridoma clones.

Authors:  J B Natvig; I Randen; K Thompson; O Førre; E Munthe
Journal:  Springer Semin Immunopathol       Date:  1989

Review 6.  What can we learn about rheumatoid arthritis from animal models?

Authors:  L Klareskog
Journal:  Springer Semin Immunopathol       Date:  1989

7.  Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads.

Authors:  Shirly Naveh; Yftah Tal-Gan; Song Ling; Amnon Hoffman; Joseph Holoshitz; Chaim Gilon
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

8.  HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients.

Authors:  B Lang; I Melchers; A Urlacher; R F Tanzi-Fetta; S Kohlbrenner; M M Tongio; H H Peter
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.

Authors:  R A Kalish; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis.

Authors:  P Emery; M Salmon; H Bradley; P Wordsworth; E Tunn; P A Bacon; R Waring
Journal:  BMJ       Date:  1992-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.